Atara Biotherapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.37

-0.44 (-4.99%)

As of Sep 28, 10:33 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 80%

Hold 2 20%

Sell 0 0%

Price Target

Analyst Price Target -15.9% upside

Low Target $5.84

Average Target $7.04

High Target $9.41

Current Price $8.37

Current
$8.37

Target
$7.04

$5.84 $7.04 avg $9.41

Scenario Analysis

Bear Case

$5.84

-30.2%

Low target

Base Case

$7.04

-15.9%

Avg target

Bull Case

$9.41

+12.4%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$19.15

-56.3% from high

52-Week Low

$3.92

+113.5% from low

Target vs 52W High

$7.04

-63.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%